Paper Details

  1. Home
  2. Paper Details

A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma.

Author: EngelstätterR, Garcia GarciaM L, ManjraAl, PedersenS, TheronI

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study compared the efficacy and safety of ciclesonide (CIC) with fluticasone propionate (FP) in children and adolescents with persistent asthma. Both treatments resulted in significant improvements in lung function, asthma symptoms, and rescue medication use, with comparable efficacy and safety profiles.
Paper Details　
Original Abstract of the Article :
Ciclesonide (CIC) is an inhaled corticosteroid (ICS) with high anti-inflammatory activity and low incidence of local and systemic adverse effects. The objective of this study was to compare the efficacy and safety of CIC with fluticasone propionate (FP) in children and adolescents with persistent as...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/ppul.20474

データ提供：米国国立医学図書館（NLM）

Inhaled Corticosteroids: Finding Relief in the Desert of Asthma

Asthma, a chronic lung condition that can make breathing feel like a struggle through a sandstorm, requires effective treatment strategies. This research delves into the efficacy and safety of two inhaled corticosteroids, ciclesonide and fluticasone propionate, in children and adolescents with persistent asthma. Researchers compared the effectiveness of these drugs in controlling asthma symptoms and improving lung function. This study offers valuable insights into the potential benefits and risks of different inhaled corticosteroid treatments.

A Oasis of Relief: Comparable Efficacy and Safety

The study reveals that ciclesonide and fluticasone propionate exhibited comparable efficacy and safety in managing asthma symptoms in children and adolescents. This finding provides reassurance for healthcare professionals seeking to choose the most appropriate treatment option for young patients with asthma. The study also suggests that ciclesonide, like a refreshing oasis in the desert, may offer a comparable level of relief while potentially reducing the risk of adverse events.

A Desert Oasis of Hope: Effective Treatment for Asthma

This research offers a beacon of hope for children and adolescents with asthma, suggesting that ciclesonide could be a viable and safe treatment option. The study underscores the importance of finding the right treatment approach for each patient, ensuring that they receive the best possible care and experience a significant improvement in their quality of life.

Dr. Camel's Conclusion

Asthma, a formidable sandstorm that can make breathing a challenge, requires effective treatment options. This research offers valuable insights into the efficacy and safety of ciclesonide and fluticasone propionate, providing healthcare professionals with a clearer understanding of these inhaled corticosteroids and their potential to bring relief to young patients with asthma.

Date :
  1. Date Completed 2007-01-11
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

16868976

DOI: Digital Object Identifier

10.1002/ppul.20474

Related Literature

Article Analysis
・Effects of ciclesonide oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.